Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Oct;72(4):1209–1217. doi: 10.1172/JCI111076

Central nervous system site of action for the respiratory depressant effect of diacetylmorphine (heroin) in the cat.

A M Taveira da Silva, J D Souza, J A Quest, F D Pagani, J M Moerschbaecher, A Buller, P Hamosh, R A Gillis
PMCID: PMC370404  PMID: 6313755

Abstract

The purpose of our study was to identify central nervous system sites involved in the respiratory depressant effect of drugs that stimulate opioid receptors. Diacetylmorphine (heroin) was administered into several cerebroventricular regions of chloralose-anesthetized cats, while monitoring pulmonary ventilation with a Fleisch pneumotachograph. Administration of heroin (17, 50, 150, and 450 micrograms) into the forebrain ventricles, which was restricted to these ventricles, resulted in no significant respiratory effects. In contrast, administration of heroin into either the fourth ventricle or the cisterna magna resulted in a significant (P less than 0.05) decrease in respiratory minute volume (VE). In the fourth ventricle this was because of a decrease in frequency (f) and in the cisterna magna, to a decrease in tidal volume (VT). Intravenous administration of heroin in the same dose-range produced a decrease in VE, which was primarily due to a decrease in f. Bilateral application of heroin (70 micrograms/side) to each of three ventral medullary surface sites (Mitchell's, Schlaefke's, and Loeschcke's areas) known to influence respiration elicited a decrease in VE only at Mitchell's area. This decrease was due to decreases in f and VT. The role of this site in the action of intravenously administered heroin was tested by topical application of naloxone to this area in animals with respiratory depression evoked by intravenous heroin. Bilateral application of naloxone (15 micrograms/side) to Mitchell's area restored breathing to normal. These results lead us to suggest that the site of heroin-induced respiratory depression is a specific area (Mitchell's area) on the ventral surface of the medulla.

Full text

PDF
1209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger A. J., Mitchell R. A., Severinghaus J. W. Regulation of respiration (first of three parts). N Engl J Med. 1977 Jul 14;297(2):92–97. doi: 10.1056/NEJM197707142970206. [DOI] [PubMed] [Google Scholar]
  2. Flórez J., McCarthy L. E., Borison H. L. A comparative study in the cat of the respiratory effects of morphine injected intravenously and into the cerebrospinal fluid. J Pharmacol Exp Ther. 1968 Oct;163(2):448–455. [PubMed] [Google Scholar]
  3. Flórez J., Mediavilla A., Pazos A. Respiratory effects of beta-endorphin, D-Ala2-met-enkephalinamide, and Met-enkephalin injected into the lateral ventricle and the pontomedullary subarachnoid space. Brain Res. 1980 Oct 13;199(1):197–206. doi: 10.1016/0006-8993(80)90240-1. [DOI] [PubMed] [Google Scholar]
  4. Flórez J., Mediavilla A. Respiratory and cardiovascular effects of met-enkephalin applied to the ventral surface of the brain stem. Brain Res. 1977 Dec 23;138(3):585–900. doi: 10.1016/0006-8993(77)90699-0. [DOI] [PubMed] [Google Scholar]
  5. Hurlé M. A., Mediavilla A., Flórez J. Morphine, pentobarbital and naloxone in the ventral medullary chemosensitive areas: differential respiratory and cardiovascular effects. J Pharmacol Exp Ther. 1982 Mar;220(3):642–647. [PubMed] [Google Scholar]
  6. Moss I. R., Friedman E. beta-Endorphin: effects on respiratory regulation. Life Sci. 1978 Sep 25;23(12):1271–1276. doi: 10.1016/0024-3205(78)90505-2. [DOI] [PubMed] [Google Scholar]
  7. Pagani F. D., Taveira da Silva A. M., Hamosh P., Garvey T. Q., 3rd, Gillis R. A. Respiratory and cardiovascular effects of intraventricular cholecystokinin. Eur J Pharmacol. 1982 Feb 19;78(1):129–132. doi: 10.1016/0014-2999(82)90382-x. [DOI] [PubMed] [Google Scholar]
  8. Pokorski M., Grieb P., Wideman J. Opiate system influences central respiratory chemosensors. Brain Res. 1981 Apr 27;211(1):221–226. doi: 10.1016/0006-8993(81)90088-3. [DOI] [PubMed] [Google Scholar]
  9. Schlaefke M. E. Central chemosensitivity: a respiratory drive. Rev Physiol Biochem Pharmacol. 1981;90:171–244. doi: 10.1007/BFb0034080. [DOI] [PubMed] [Google Scholar]
  10. Speck D. F., Feldman J. L. The effects of microstimulation and microlesions in the ventral and dorsal respiratory groups in medulla of cat. J Neurosci. 1982 Jun;2(6):744–757. doi: 10.1523/JNEUROSCI.02-06-00744.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tress K. H., El-Sobky A. A. Cardiovascular, respiratory and temperature responses to intravenous heroin (diamorphine) in dependent and non-dependent humans. Br J Clin Pharmacol. 1980 Nov;10(5):477–485. doi: 10.1111/j.1365-2125.1980.tb01792.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Yamada K. A., Hamosh P., Gillis R. A. Respiratory depression produced by activation of GABA receptors in hindbrain of cat. J Appl Physiol Respir Environ Exerc Physiol. 1981 Nov;51(5):1278–1286. doi: 10.1152/jappl.1981.51.5.1278. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES